Substituted quinobenzoxazine analogs

Details for Australian Patent Application No. 2004229489 (hide)

Owner Cylene Pharmaceuticals, Inc.

Inventors Schwaebe, Michael; Siddiqui-Jain, Adam; Moran, Terrance; Whitten, Jeffrey P.

Agent Pizzeys

Pub. Number AU-B-2004229489

PCT Pub. Number WO2004/091504

Priority 60/532,727 23.12.03 US; 60/461,271 07.04.03 US; 60/519,535 12.11.03 US; 60/463,171 15.04.03 US

Filing date 7 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 4 March 2010

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 265/38 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 471/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/16 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091504 Priority application(s): WO2004/091504

24 November 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Cyclene Pharmaceuticals, Inc. to Cylene Pharmaceuticals, Inc.

4 March 2010 Application Accepted

  Published as AU-B-2004229489

15 July 2010 Standard Patent Sealed

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229497-Fullerene compositions for ameliorating dermatological conditions

2004229488-Systems and methods for respiratory event detection